Home Other Building Blocks 5-Chlorouracil

5-Chlorouracil

CAS No.:
1820-81-1
Catalog Number:
AG00239S
Molecular Formula:
C4H3ClN2O2
Molecular Weight:
146.5318
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
98%
In Stock USA
United States
$13
- +
25g
98%
In Stock USA
United States
$32
- +
100g
98%
In Stock USA
United States
$100
- +
500g
98%
In Stock USA
United States
$350
- +
Product Description
Catalog Number:
AG00239S
Chemical Name:
5-Chlorouracil
CAS Number:
1820-81-1
Molecular Formula:
C4H3ClN2O2
Molecular Weight:
146.5318
MDL Number:
MFCD00006019
IUPAC Name:
5-chloro-1H-pyrimidine-2,4-dione
InChI:
InChI=1S/C4H3ClN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)
InChI Key:
ZFTBZKVVGZNMJR-UHFFFAOYSA-N
SMILES:
Clc1c[nH]c(=O)[nH]c1=O
EC Number:
217-339-7
UNII:
7LQ4V03RNY
NSC Number:
28172
Properties
Complexity:
199  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
145.988g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
146.53g/mol
Monoisotopic Mass:
145.988g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
58.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.3  
Literature
Title Journal
Protonation preferentially stabilizes minor tautomers of the halouracils: IRMPD action spectroscopy and theoretical studies. Journal of the American Society for Mass Spectrometry 20120901
A spectroscopic investigations of anticancer drugs binding to bovine serum albumin. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120301
A rapid HPLC-ESI-MS/MS method for determination of dihydrouracil/uracil ratio in plasma: evaluation of toxicity to 5-flurouracil in patients with gastrointestinal cancer. Therapeutic drug monitoring 20120201
Benzene metabolite 1,2,4-benzenetriol induces halogenated DNA and tyrosines representing halogenative stress in the HL-60 human myeloid cell line. Environmental health perspectives 20120101
Electron transfer processes in potassium collisions with 5-fluorouracil and 5-chlorouracil. Physical chemistry chemical physics : PCCP 20111228
Chemical evolution of a bacterium's genome. Angewandte Chemie (International ed. in English) 20110725
Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study. Cancer chemotherapy and pharmacology 20110501
Photoelectron spectroscopic study of the negative ions of 4-thiouracil and 2,4-dithiouracil. The Journal of chemical physics 20110221
Photoelectron spectroscopic studies of 5-halouracil anions. The Journal of chemical physics 20110107
Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. Journal of clinical biochemistry and nutrition 20110101
Anti-proliferation effects of Sirolimus sustained delivery film in rabbit glaucoma filtration surgery. Molecular vision 20110101
Epigenomics in environmental health. Frontiers in genetics 20110101
Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV. Cancer science 20100801
Polymerase incorporation and miscoding properties of 5-chlorouracil. Chemical research in toxicology 20100419
A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma. Biomedical chromatography : BMC 20100401
Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts--potential use in drug-eluting glaucoma drainage devices. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20100201
Comparative study of HOCl-inflicted damage to bacterial DNA ex vivo and within cells. Archives of biochemistry and biophysics 20100115
[Markers of chloric acid (I) in biological systems--identification and properties]. Postepy biochemii 20100101
pH-Dependent configurations of a 5-chlorouracil-guanine base pair. Biochemistry 20091201
Base pairing configuration and stability of an oligonucleotide duplex containing a 5-chlorouracil-adenine base pair. Biochemistry 20090811
Retrospective analysis of S-1 monotherapy in patients with metastatic colorectal cancer after failure to fluoropyrimidine and irinotecan or to fluoropyrimidine, irinotecan and oxaliplatin. Japanese journal of clinical oncology 20090501
Significance of 5-fluorouracil-related enzyme activities in predicting sensitivity to 5-fluorouracil in bladder carcinoma. Anticancer research 20090401
Reactive oxygen and nitrogen species induce protein and DNA modifications driving arthrofibrosis following total knee arthroplasty. Fibrogenesis & tissue repair 20090101
Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma. Investigative ophthalmology & visual science 20080701
Examination of hypochlorous acid-induced damage to cytosine residues in a CpG dinucleotide in DNA. Chemical research in toxicology 20080601
[Clinical benefit of S-1 in metastatic breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy 20060601
Myeloperoxidase generates 5-chlorouracil in human atherosclerotic tissue: a potential pathway for somatic mutagenesis by macrophages. The Journal of biological chemistry 20060210
Evaluation of novel one-electron reduction with metal in DNA. Nucleic acids symposium series (2004) 20060101
Hydrophilic interaction liquid chromatography-APCI-mass spectrometry determination of 5-fluorouracil in plasma and tissues. Journal of pharmaceutical and biomedical analysis 20050715
Measurement of drug release from microcarriers by microdialysis. Journal of pharmaceutical sciences 20050701
Influence of halogenation on the properties of uracil and its noncovalent interactions with alkali metal ions. Threshold collision-induced dissociation and theoretical studies. Journal of the American Chemical Society 20041215
Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. British journal of cancer 20041004
Synthesis and characterization of oligonucleotides containing 5-chlorocytosine. Chemical research in toxicology 20040901
Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 20040801
Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase. Bioorganic & medicinal chemistry 20040701
Alternate-day oral therapy with TS-1 for advanced gastric cancer. International journal of clinical oncology 20040601
Electron attachment to chlorouracil: a comparison between 6-ClU and 5-ClU. The Journal of chemical physics 20040108
Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer. International journal of clinical oncology 20031201
5-Chlorouracil, a marker of DNA damage from hypochlorous acid during inflammation. A gas chromatography-mass spectrometry assay. The Journal of biological chemistry 20030829
Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. The Journal of biological chemistry 20030627
Analytical and pharmacokinetic studies with 5-chloro-2'-deoxycytidine. Biochemical pharmacology 20021115
Loss of oxidized and chlorinated bases in DNA treated with reactive oxygen species: implications for assessment of oxidative damage in vivo. Biochemical and biophysical research communications 20020830
Detection and quantification of 5-chlorocytosine in DNA by stable isotope dilution and gas chromatography/negative ion chemical ionization/mass spectrometry. Chemical research in toxicology 20020201
An improved resazurin-based cytotoxicity assay for hepatic cells. Cell biology and toxicology 20020101
N(1)-C(5')-linked dimer hydrates of 5-substituted uracils produced by anodic oxidation in aqueous solution. The Journal of organic chemistry 20010406
Simultaneous determination of flucytosine and fluorouracil in human plasma by high-performance liquid chromatography. Biomedical chromatography : BMC 20010401
Determination of 5-fluorouracil in environmental samples by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. Journal of chromatography. B, Biomedical sciences and applications 20010105
Synthesis of 5-chloro-1-(2,3-dideoxy-3-fluoro-beta-D-glycero-hex-2- enopyranose-4-ulosyl)uracil as potential anticancer/antiviral agent. Nucleosides, nucleotides & nucleic acids 20010101
Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii. Biochemical pharmacology 19940817
Synthesis, structure, and antitumor and antiviral activities of a series of 5-halouridine cyclic 3',5'-monophosphates. Journal of medicinal chemistry 19860401
Interaction of monoclonal antibodies directed against bromodeoxyuridine with pyrimidine bases, nucleosides, and DNA. Journal of immunology (Baltimore, Md. : 1950) 19860301
Properties